National Institute of General Medical Sciences; Notice of Meeting, 79052-79053 [2015-31772]
Download as PDF
<![CDATA[
79052
Federal Register / Vol. 80, No. 243 / Friday, December 18, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; AGING
STUDY.
Date: January 20, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Carmen Moten, Ph.D.,
M.P.H., National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7703,
cmoten@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 11, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–31771 Filed 12–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Prospective Grant of Exclusive
License: Development of a Small
Molecule Farnesoid X Receptor
Inhibitor
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Cancer Institute (NCI),
National Institutes of Health,
Department of Health and Human
SUMMARY:
VerDate Sep<11>2014
19:20 Dec 17, 2015
Jkt 238001
Services, is contemplating the grant of
an exclusive patent license to practice
the inventions embodied in the
following U.S. Patents and Patent
Applications to Heliome Biotech, Inc.
(‘‘Heliome’’) located in New York, NY,
USA.
Intellectual Property:
1. United States Provisional Patent
Application No. 61/861,109, filed
August 1, 2013 ‘‘Inhibitors of the
Farnesoid X Receptor and Use
Thereof in the Prevention of Weight
Gain’’ [HHS Reference No. E–508–
2013/0–US–01];
2. United States Provisional Patent
Application No. 62/004,436, filed
May 29, 2014, entitled ‘‘Methods of
Treating or Preventing Obesity,
Insulin Resistance and NonAlcoholic Fatty Liver Disease’’
[HHS Reference No. E–508–2013/1–
US–01]; and
3. PCT Patent Application No. PCT/
US2014/49460 filed August 1, 2014
‘‘Inhibitors of the Farnesoid X
Receptor and Uses in Medicine’’
[HHS Reference No. E–508–2013/2–
PCT–01].
The patent rights in these inventions
have been assigned to the government of
the United States of America.
The prospective exclusive license
territory may be worldwide and the
field of use may be limited to the use
of the Licensed Patent Rights to make or
have made, use and sell a small
molecule farnesoid X receptor inhibitor
for all metabolic diseases.
DATES: Only written comments and/or
applications for a license which are
received by the NCI Technology
Transfer Center on or before January 4,
2016 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, and
comments relating to the contemplated
exclusive license should be directed to:
Thomas Clouse, J.D., Senior Licensing
and Patenting Manager, NCI Technology
Transfer Center, 9609 Medical Center
Drive, RM 1E530 MSC 9702, Bethesda,
MD 20892–9702 (for business mail),
Rockville, MD 20850–9702 Telephone:
(240)–276–5530; Facsimile: (240)–276–
5504 Email: thomas.clouse@nih.gov.
SUPPLEMENTARY INFORMATION:
Remodeling the gut microbiota using
specific compounds can affect high fat
diet-induced obesity through signal
transduction mediated by the nuclear
receptor farnesoid X receptor (FXR).
FXR is inhibited due to the altered gut
microbiota as a result of lack of
metabolism (bile salt hydrolase activity)
of a potent FXR antagonist tauro-bmuracholic acid (TbMCA) that is
produced in the liver and secreted to the
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
intestine. The technology identifies a
class of compounds that specifically
decrease levels of Lactobacillusassociated bile salt hydrolase activity
resulting in accumulation of intestinal
TbMCA which is now identified as an
antagonist of FXR. The technology has
the potential of being developed into a
therapeutic for various metabolic
disorders associated with inhibition of
the farnesoid X receptor pathway,
including Non-Alcoholic Fatty Liver
Disease (NAFLD), Type 2 Diabetes, and
non-alcoholic steatohepatitis (NASH).
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR part 404. The
prospective exclusive license may be
granted unless within fifteen (15) days
from the date of this published notice,
the NCI receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: December 15, 2015.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2015–31831 Filed 12–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory General Medical
Sciences Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end.
Attendance is limited by the space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will also be videocast and can
E:\FR\FM\18DEN1.SGM
18DEN1
Federal Register / Vol. 80, No. 243 / Friday, December 18, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
be accessed from the NIH Videocasting
and Podcasting Web site (https://
videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property, such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: January 28–29, 2016.
Closed: January 28, 2016, 8:30 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Open: January 29, 2016, 8:30 a.m. to
Adjournment.
Agenda: For the discussion of program
policies and issues, opening remarks, report
of the Director, NIGMS, and other business
of the Council.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D.,
Associate Director for Extramural Activities,
NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24B, MSC 6200, Bethesda, MD 20892,
(301) 594–4499, hagana@nigms.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles,
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit. Information is also available on the
Institute’s home page (https://
www.nigms.nih.gov/About/Council/) where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 11, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–31772 Filed 12–17–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:20 Dec 17, 2015
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Application (P01).
Date: January 12, 2016.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3G61, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3G30, National
Institues of Health/NIAID, 5601 Fishers Lane,
Drive, MSC 9823, Bethesda, MD 20892–9823,
240–669–5058, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 14, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–31770 Filed 12–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
79053
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Radiation Biology.
Date: January 5, 2016.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M. Quadri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–31767 Filed 12–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Workshop on Addressing Challenges
in the Assessment of Botanical Dietary
Supplement Safety; Notice of Public
Meeting; Registration Information
The National Toxicology
Program (NTP) announces the public
workshop, ‘‘Addressing Challenges in
the Assessment of Botanical Dietary
Supplement Safety.’’ Presenters from
academia, government, and industry
will introduce the challenges in
assessing botanical dietary supplement
safety and present various approaches
that could facilitate progress in three
focus areas. The workshop will consist
of plenary presentations and panel
discussions. Information about the
meeting and registration is available at
(https://ntp.niehs.nih.gov/go/workshop_
botanicals).
DATES: Meeting: April 26–27, 2016, from
9 a.m. to approximately 5 p.m. Eastern
Daylight Time (EDT).
SUMMARY:
E:\FR\FM\18DEN1.SGM
18DEN1
]]>Agencies
[Federal Register Volume 80, Number 243 (Friday, December 18, 2015)]
[Notices]
[Pages 79052-79053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31772]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory General Medical Sciences Council.
The meeting will be open to the public as indicated below, with a
short public comment period at the end. Attendance is limited by the
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The open session will also be videocast and can
[[Page 79053]]
be accessed from the NIH Videocasting and Podcasting Web site (https://videocast.nih.gov/).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property, such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory General Medical Sciences
Council.
Date: January 28-29, 2016.
Closed: January 28, 2016, 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
Open: January 29, 2016, 8:30 a.m. to Adjournment.
Agenda: For the discussion of program policies and issues,
opening remarks, report of the Director, NIGMS, and other business
of the Council.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D., Associate Director for
Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24B, MSC 6200, Bethesda, MD 20892, (301) 594-4499,
hagana@nigms.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and, when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit. Information is also available on the Institute's home page
(https://www.nigms.nih.gov/About/Council/) where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Biomedical Research and Research Training, National Institutes of
Health, HHS)
Dated: December 11, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-31772 Filed 12-17-15; 8:45 am]
BILLING CODE 4140-01-P
